STC2
Reaktivität: Human
WB, ELISA, IF (cc), IF (p), ICC, IHC (p), IHC (fro)
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
In 1x PBS, pH 7.4
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Na, Aldonza, Sung, Kim, Son, Cho, Cho: "Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression." in: Biochimica et biophysica acta, Vol. 1854, Issue 6, pp. 668-76, (2015) (PubMed).
Miyazaki, Kikuchi, Iino, Uehara, Setoguchi, Fujita, Hiramatsu, Ohta, Kamiya, Kitagawa, Kitagawa, Baba, Konno: "Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts." in: International journal of cancer. Journal international du cancer, Vol. 135, Issue 2, pp. 295-307, (2014) (PubMed).
Kita, Mimori, Iwatsuki, Yokobori, Ieta, Tanaka, Ishii, Okumura, Natsugoe, Mori: "STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma." in: Annals of surgical oncology, Vol. 18, Issue 1, pp. 261-72, (2011) (PubMed).
Yokobori, Mimori, Ishii, Iwatsuki, Tanaka, Kamohara, Ieta, Kita, Doki, Kuwano, Mori: "Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer." in: Annals of surgical oncology, Vol. 17, Issue 10, pp. 2601-7, (2010) (PubMed).